Disclosure Information2026-10-23 05:30:00 (KST)
No Date Title Submitter
23 2026/07/09 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
22 2026/07/09 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
21 2026/07/09 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
20 2026/07/01 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
19 2026/07/01 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
18 2026/07/01 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
17 2026/06/15 Other Management Information(Voluntary Disclosure) Prestige BioPharma Limited
16 2026/06/01 Details of Corporate Governance Report Prestige BioPharma Limited
15 2026/05/29 Quarterly Report (2026.03) Prestige BioPharma Limited
14 2026/03/13 [Corrected description]Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
13 2026/03/03 Semi-annual Report (2025.12) Prestige BioPharma Limited
12 2026/01/29 [Corrected description]Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
11 2026/01/21 Report on the Appointment, Dismissal or Early Retirement of Independent Directors Prestige BioPharma Limited
10 2026/01/21 Outcome of Extraordinary Shareholders' Meeting Prestige BioPharma Limited
9 2026/01/06 Announcement of convocation of general meeting of shareholders Prestige BioPharma Limited